Wednesday, December 11, 2024
IT / EN
Publications
December 1, 2015 | Publications, Books | By MG

The Economics of Infrastructure Provisioning

The Changing Role of the State, the MIT Press, 2015. Edited by Arnold Picot, Massimo Florio, Nico Grove and Johann Kranz

October 25, 2014 | Publications, Books | By MG

Guide to Cost-Benefit Analysis of Investment Projects

Economic appraisal tool for Cohesion Policy 2014-2020, European Commission, Directorate-General for Regional and Urban Policy, 2014.

February 25, 2014 | Publications, Books | By MG

Applied Welfare Economics

Cost-Benefit Analysis of Projects and Policies, Routledge, February 2014, authored by Massimo Florio.

February 25, 2013 | Publications, Books | By MG

Network Industries and Social Welfare

The Experiment that Reshuffled European Utilities, Oxford University Press, 2013, authored by Massimo Florio

March 11, 2011 | Publications, Articles | By MG

Shadow Wages for the EU Regions

Chiara Del Bo, Carlo Fiorio and Massimo Florio. Fiscal Studies, Volume32, Special Issue on Cost‐Benefit Analysis, 109-143

February 25, 2011 | Publications, Books | By MG

Public Investment, Growth and Fiscal Constraints

Challenges for the EU New Member States, Edward Elgar, 2011, edited by Massimo Florio

February 25, 2007 | Publications, Books | By MG

Cost-Benefit Analysis and Incentives in Evaluation

The Structural Funds of European Union, Edward Elgar, 2007, edited by Massimo Florio

February 25, 2004 | Publications, Books | By MG

The Great Divestiture

Evaluating the welfare impact of the British privatisations 1979-1997, The Mit Press, 2004, authored by Massimo Florio

Highlights

Which Europe. To know, discuss, choose
"The European Union has a central role to play on the road to social and environmental justice for all of us [...]"
Some questions on the future of R&D on Covid-19 vaccines
A conversation between Massimo Florio and Giuseppe Remuzzi - WP CSIL N. 01/2024
Study for Panel for the Future of Science and Technology (STOA), European Parliament
European pharmaceutical research and development: Could public infrastructure overcome market failures?
Arrow to go back to the top of the page.